Argitalpenak (93) Cristian Smerdou Picazo argitalpenak

filter_list

2025

  1. COVID-19 mRNA vaccines are effective at stopping a nosy virus

    Molecular Therapy Nucleic Acids

  2. Immunocytokines based on IL-12 for cancer therapy: Enhancing efficacy and reducing toxicity

    International Review of Cell and Molecular Biology (Elsevier Inc.)

  3. Targeting PD-1+ T cells with small-format immunocytokines enhances IL-12 antitumor activity

    Molecular Therapy, Vol. 33, Núm. 1, pp. 297-316

2024

  1. A Dual-Armed Oncolytic Virus Shows Clinical Efficacy in Advanced Solid Cancers

    Clinical Cancer Research, Vol. 30, Núm. 17, pp. 3649-3651

  2. Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope

    Molecular Therapy Nucleic Acids

  3. Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity

    ANTIBODIES, Vol. 13, Núm. 2

  4. DNA electroporation in a vacuum: A “shocking” innovation for vaccines

    Molecular Therapy Nucleic Acids

  5. Effective cancer immunotherapy combining mRNA-encoded bispecific antibodies that induce polyclonal T cell engagement and PD-L1-dependent 4-1BB costimulation

    Frontiers in Immunology, Vol. 15

  6. Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies

    British Journal of Cancer, Vol. 130, Núm. 5, pp. 869-879

  7. Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19

    Vaccines, Vol. 12, Núm. 3

  8. Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2 -infected mice and reduces endotheliopathy

    eBioMedicine, Vol. 103

2023

  1. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

  2. Checkpoint blockade meets gene therapy: Opportunities to improve response and reduce toxicity

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 43-86

  3. JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology

    ACS Chemical Neuroscience

  4. JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding

    ACS Chemical Neuroscience, Vol. 14, Núm. 11, pp. 2074-2088

  5. Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors

    Cancers, Vol. 15, Núm. 8

  6. Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses

    Cancer Letters, Vol. 561

  7. Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  8. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice

    Aging Cell, Vol. 22, Núm. 3

2022

  1. A minimal bile salt excretory pump promoter allows bile acid-driven physiological regulation of transgene expression from a gene therapy vector

    Cell and Bioscience, Vol. 12, Núm. 1